The mortality consequences of the continued use of chloroquine in Africa: Experience in Siaya, Western Kenya

American Journal of Tropical Medicine and Hygiene

Volumn 68, Issue 4, 2003, Pages 386-390

  Zucker, Jane R ^a   Ruebush II, Trenton K ^b   Obonyo, Charles ^c   Otieno, Juliana ^d   Campbell, Carlos C ^e  

^a NY City Dept of Hlth/Mental Hyg   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d Kisumu Provincial Hospital   (Kenya)

^e UNICEF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; COTRIMOXAZOLE; HEMOGLOBIN; PYRIMETHAMINE; QUININE; ANTIMALARIAL AGENT;

AFRICA; ANEMIA; ARTICLE; BLOOD SMEAR; CHILD; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA; MORTALITY; PLASMODIUM FALCIPARUM; POLICY; ANIMAL; DRUG EFFECT; DRUG RESISTANCE; EVALUATION; INFANT; MALARIA FALCIPARUM; NEWBORN; PARASITEMIA; PRESCHOOL CHILD; PREVALENCE; TREATMENT OUTCOME;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE; TREATMENT OUTCOME;

EID: 0041806474     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.68.386     Document Type: Article

References (28)

1. World Health Organization, 1993. Implementation of the Global Malaria Control Strategy. Report of a WHO Study Group on the Implementation of the Global Plan of Action for Malaria Control 1993-2000. Technical Report Series no. 839. Geneva: World Health Organization.
2. Bloland PB, Lackritz EM, Kazembe PN, Were JBO, Steketee R Campbell CC, 1993. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167: 932-937.
3. Greenwood BM, 1987. Asymptomatic malaria infections-do they matter? Parasitol Today 3: 206-214.
4. Zucker JR, Lackritz EM, Ruebush TK, Hightower AW, Adungosi JE, Were JBO, Metchock B, Patrick E, Campbell CC, 1996. Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. Am J Trop Med Hyg 55: 655-660.
5. Hennekens CH, Buring JE, 1987. Epidemiology in Medicine. Mayrent SL, ed. Boston: Little, Brown and Co., 66-73.
6. Greenberg AE, Ntumbanzondo M, Ntula N, Mawa L, Howell J, Davachi F, 1989. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull World Health Organ 67: 189-196.
7. White NJ, Krishna S, 1989. Treatment of malaria: some considerations and limitations of the current methods of assessment. Trans R Soc Trop Med Hyg 83: 767-777.
8. World Health Organization, Division of Control of Tropical Diseases, 1994. Antimalarial drug policies: data requirements, treatment of uncomplicated malaria and management of malaria in pregnancy. Report of an informal consultation, Geneva, March 14-18, 1994. WHO/MAL/94.1070.
9. World Health Organization, Division of Control of Tropical Diseases, 1996. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas of intense transmission. WHO/MAL/96.1077.
10. Schapira A, Beales PF, Halloran ME, 1993. Malaria: living with drug resistance. Parasitol Today 9: 168-173.
11. Sudre P, Breman JG, McFarland D, Koplan JP, 1992. Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. Int J Epidemiol 21: 146-154.
12. Campbell CC, 1991. Challenges facing antimalarial therapy in Africa. J Infect Dis 163: 1207-1211.
13. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK, Danis M, Greenwood BM, Anderson RM, Olliaro P, 1999. Averting a malaria disaster. Lancet 353: 1965-1967.
14. Hogh B, Gamage-Mendis A, Butcher GA, Thompson R, Begtrup K, Mendis C, Enosse SM, Dgedge M, Barreto J, Eling W, Sindin RE, 1998. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am J Trop Med Hyg 58: 176-182.
15. Brandts CH, Wernsdorfer WH, Kremsner PG, 2000. Decreasing chloroquine resistance in Plasmodium falciparum isolates from Gabon. Trans R Soc Trop Med Hyg 94: 554-556.
16. Greenberg AE, Lobel HO, 1990. Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987. Ann Intern Med 113: 326-327.
17. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow R, 1995. Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404.
18. World Health Organization, 1990. Severe and complicated malaria. Warrell DA, Molyneux ME, Beales PF, eds. Trans R Soc Trop Med Hyg 84(suppl. 2): 1-65.
19. Barutwanayo M, Bassalia D, Birabuza A, Delacollette C, Keita M, Madji N, Maiga AS, Maoude H, Ndihokubwayo H, Niangue J, Lemine SMOM, Yazipo ED, 1993. Malaria control in Africa: guidelines for the evaluation of national programs. U.S. Agency for International Development and U.S. Department of Health and Human Services, Atlanta, Publication No. 099-4243.
20. Greenwood BM, Greenwood AM, Bradley AK, Tulloch S, Hayes R, Oldfield FSJ, 1987. Deaths in infancy and early childhood in a well-vaccinated, rural, East African population. Ann Trop Paediatr 7: 91-99.
21. Trape JF, Pison G, Preziosi MP, Enel C, Desgrées du Loû A, Delaunay V, Samb B, Lagarde E, Molez JF, Simondon F, 1998. Impact of chloroquine resistance on malaria mortality. C.R. Acad Sci Paris, Life Sciences 321: 689-697.
22. Marsh K, 1998. Malaria disaster in Africa. Lancet 352: 924-925.
23. Hogh B, Thompson R, Hetzel C, Fleck SL, Kruse NAA, Jones I, Dgedge M, Barreto J, Sinden RE, 1995. Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique. Am J Trop Med Hyg 52: 50-59.
24. Del Nero L, Nebie I, Soudouem G, Pietra V, 1994. Chloroquine and sulfadoxine/pyrimethamine sensitivity in Burkina Faso. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Burkina Faso. Trop Geogr Med 46: 8-10.
25. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W, 1994. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis 169: 467-470.
26. Mharakurwa S, Mugochi T, 1994. Chloroquine-resistant falciparum malaria in an area of rising endemicity in Zimbabwe. J Trop Med Hyg 97: 39-45.
27. Premji Z, Minjas JN, Shiff CJ, 1994. Chloroquine-resistant Plasmodium falciparum in coastal Tanzania. A challenge to the continued strategy of village-based chemotherapy for malaria control. Trop Med Parasitol 45: 47-48.
28. Schreuder HW, Wolters FL, de Vries G, Wetsteyn JC, 1993. Prospective in-vivo study of chloroquine resistance of Plasmodium falciparum in Zambian under-fives. Trop Geogr Med 45: 15-17.